Compare CSX Corporation (CSX) vs Procter & Gamble Co (PG) Price & Performance

CSX trades at $50.27, down 0.85% on the day, with a neutral technical signal and bullish moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.54 versus $0.518 expected, driven by 10% revenue growth and 17% operating income increase. The company raised 2026 guidance to mid-to-high-single-digit revenue growth and margin expansion. Analyst consensus is bullish with 59% buy ratings and a $52.57 price target, implying 4.6% upside from current levels.

Outlook remains positive due to strong volume growth and operational efficiency, but risks include fuel cost pressures and economic sensitivity. The stock offers value through consistent dividends and earnings momentum, though valuation multiples appear elevated with P/E at 29.23. Investors should monitor execution against raised guidance and industry headwinds.

Procter & Gamble (PG) trades at $144.84, down 0.64% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.90. Fundamentals show robust profitability, including an 18.44% net income margin and 30.13% ROE, though valuation ratios like P/E of 22.12 and P/S of 4.08 are at premiums. Recent news highlights a WNBA partnership and a rejected mini-tender offer, while cash flow trends indicate stable operations.

PG offers a stable outlook with consistent dividend growth and efficient supply chain improvements, but faces risks from premium valuations and soft demand concerns. Analyst consensus is bullish with a $161.20 price target, though near-term upside may be limited by economic headwinds. Investment appeal lies in its defensive qualities and dividend reliability, balanced against competitive and margin pressures.